About

Publications While At HealthPartners

selected publications

Journal Article

A randomized, phase III trial to evaluate rucaparib monotherapy as maintenance treatment in patients with newly diagnosed ovarian cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45). 

Journal of Clinical Oncology. 2022

Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study. 

Gynecologic Oncology. 2022

Quality of life and adverse events: prognostic relationships in long-term ovarian cancer survival. 

Journal of the National Cancer Institute. 2021

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study. 

Annals of Oncology. 2017

Contact

full name

B. J. Monk

Quick Info

 

Collaboration

Co-author network

Map of science